metastatic liver cancer
Showing 1 - 25 of 27
Primary Liver Cancer, Metastatic Liver Cancer, Benign Liver Tumors Trial
Not yet recruiting
- Primary Liver Cancer
- +3 more
- (no location specified)
Aug 1, 2023
PDO/PDO-TIL/PDOTS for Drug Screen
Recruiting
- Liver Cancer
- Metastatic Liver Cancer
- Drug screen with PDO/PDO-TIL/PDOTS
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jun 13, 2023
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ECT204 T cells
-
Duarte, California
- +1 more
Jan 9, 2023
Metastatic Liver Cancer Trial in Shanghai (HAIC?Bevacizumab?Camrelizumab)
Not yet recruiting
- Metastatic Liver Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 7, 2022
Hepatocellular Carcinoma, Metastatic Liver Cancer Trial (BioTraceIO 360)
Not yet recruiting
- Hepatocellular Carcinoma
- Metastatic Liver Cancer
- BioTraceIO 360
- (no location specified)
Nov 29, 2022
Hepatocellular Carcinoma, Metastatic Liver Cancer Trial (BioTraceIO 360)
Not yet recruiting
- Hepatocellular Carcinoma
- Metastatic Liver Cancer
- BioTraceIO 360
- (no location specified)
Oct 12, 2022
Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)
Recruiting
- Hepatoblastoma
- +5 more
- ET140203 T Cells
-
Boston, MassachusettsDana-Farber/Boston Children's Cancer and Blood Disorders Center
Aug 12, 2022
Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ET140203 autologous T cell product
-
Duarte, California
- +3 more
Jul 1, 2022
BioTraceIO Lite for Tissue Damage Assessment Following Liver
Recruiting
- Carcinoma, Hepatocellular
- Metastatic Liver Cancer
- BioTraceIO Lite
-
Phoenix, Arizona
- +5 more
Mar 23, 2022
Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)
Not yet recruiting
- Liver Diseases
- +27 more
- Liver Transplantation
-
Murcia, SpainFelipe Alconchel
Feb 24, 2022
Colorectal Cancer, Metastatic Liver Cancer Trial in Shanghai (Anti-CEA CAR-T Cells)
Recruiting
- Colorectal Cancer
- Metastatic Liver Cancer
- Anti-CEA CAR-T Cells
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery in Changhai Hospital
Mar 9, 2022
Treat Primary and Metastatic Liver Tumors
Enrolling by invitation
- Intrahepatic Cholangiocarcinoma
- +3 more
-
Dallas, TexasMethodist Dallas Medical Center
Feb 3, 2022
Colorectal Cancer, Metastatic Liver Cancer, Liver Metastases Trial in Valencia (Liver transplantation)
Recruiting
- Colorectal Cancer
- +2 more
- Liver transplantation
-
Valencia, SpainEva M Montalvá
Sep 15, 2021
Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in Duarte, Irvine, Sacramento (ET140202 autologous T cell product)
Terminated
- Hepatocellular Carcinoma
- +3 more
- ET140202 autologous T cell product
-
Duarte, California
- +2 more
Apr 14, 2021
Chemotherapy for Resectable Colorectal Liver Metastases
Completed
- Metastatic Colorectal Cancer
- Metastatic Liver Cancer
- Liver resection and Neoadjuvant chemotherapy
- +3 more
-
Reims, France
- +8 more
Mar 26, 2021
Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells
Completed
- Hepatocellular Carcinoma
- +3 more
- ET1402L1-ARTEMIS™ T cells -IV
- +2 more
-
Xi'an, ChinaThe First Affiliated Hospital of Xi'an Jiaotong University
Mar 26, 2021
Cancer, Lung, Perfusion Computed Tomography Target Lesion, Cancer Liver Trial in Ghent (Extra DCE-CT scan)
Recruiting
- Cancer, Lung
- +4 more
- Extra DCE-CT scan
-
Ghent, East-Flanders, BelgiumUniversity Hospital, Ghent
Feb 8, 2021
Primary Liver Cancer, Metastatic Liver Cancer Trial in Halifax (Primovist)
Withdrawn
- Primary Liver Cancer
- Metastatic Liver Cancer
-
Halifax, Nova Scotia, CanadaNova Scotia Cancer Centre
Jan 25, 2021
Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (Sorafenib combined with ET140202-T cell, TAE combined with
Unknown status
- Hepatocellular Carcinoma
- +3 more
- Sorafenib combined with ET140202-T cell
- +2 more
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi'an Jiaotong University
Aug 6, 2019
Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Wuhan (autologous ET1402L1-CART cells)
Terminated
- Hepatocellular Carcinoma
- +3 more
- autologous ET1402L1-CART cells
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Jun 27, 2019
Hepatocellular Cancer, Metastatic Liver Cancer Trial in Houston (TACE, Y-90, MWA)
Terminated
- Hepatocellular Cancer
- Metastatic Liver Cancer
- TACE
- +3 more
-
Houston, TexasUniversity of Texas Health Science Center Houston
Oct 16, 2018
Metastatic Liver Cancer, Secondary Liver Cancer, Liver Tumor Trial in New York, Cleveland (Radiofrequency Ablation (RFA),
Withdrawn
- Metastatic Liver Cancer
- +2 more
- Radiofrequency Ablation (RFA)
- Chemotherapy
-
New York, New York
- +1 more
Mar 2, 2017
Metastatic Liver Cancer Trial in Philadelphia (SIRT, capecitabine)
Completed
- Metastatic Liver Cancer
- SIRT
- capecitabine
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 3, 2015
Metastatic Liver Cancer Trial in Seoul (DCE MRI)
Completed
- Metastatic Liver Cancer
- DCE MRI
-
Seoul, Korea, Republic ofAsan Medical Center
Jun 22, 2015
Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma Trial in United States (Melphalan, Percutaneous Hepatic Perfusion)
No longer available
- Metastatic Liver Cancer
- +2 more
- Melphalan
- Percutaneous Hepatic Perfusion
-
Santa Monica, California
- +5 more
Oct 22, 2013